WASL and idiopathic pulmonary fibrosis: This research marks a preliminary foray into understanding the role of TUFT1 in fibrotic diseases, introduces a novel pathogenic mechanism in the realm of IPF research, and evaluates the potential of N-WASP-F-actin as a therapeutic target for combating pulmonary fibrosis.